Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 21 | 0 | 0 | 0 | 0 |
| Cost of Goods | 6 | N/A | 0 | 0 | 0 |
| Gross Profit | 15 | N/A | 0 | 0 | 0 |
| Operating Expenses | 2,680 | 1,902 | 1,759 | 1,977 | 1,780 |
| Operating Income | -2,659 | -1,902 | -1,759 | -1,977 | -1,780 |
| Interest Expense | 1 | 1 | 0 | 1 | 3 |
| Other Income | 67 | -174 | 159 | 216 | 94 |
| Pre-tax Income | -2,594 | -2,077 | -1,600 | -1,763 | -1,689 |
| Net Income Continuous | -2,594 | -2,077 | -1,600 | -1,763 | -1,689 |
| Net Income | $-2,594 | $-2,077 | $-1,600 | $-1,763 | $-1,689 |
| EPS Basic Total Ops | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 |
| EPS Basic Continuous Ops | -0.47 | -0.46 | -0.39 | -0.42 | -0.41 |
| EPS Diluted Total Ops | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 |
| EPS Diluted Continuous Ops | -0.47 | -0.46 | -0.39 | -0.42 | -0.41 |
| EBITDA(a) | $-2,602 | $-1,854 | $-1,711 | $-1,929 | $-1,730 |